Recent News

• 03.10.2025 - Fireside chat at Leerink Global Healthcare Conference
• 03.10.2025 - Fireside chat at Leerink Global Healthcare Conference
• 03.10.2025 - Fireside chat at Leerink Global Healthcare Conference
• 03.10.2025 - Fireside chat at Leerink Global Healthcare Conference
• 03.10.2025 - Fireside chat at Leerink Global Healthcare Conference
• 03.06.2025 - Xeris Biopharma Fourth Quarter and Full-year 2024 Financial Results Conference Call and Webcast
• 03.06.2025 - Xeris Biopharma Fourth Quarter and Full-year 2024 Financial Results Conference Call and Webcast
• 03.06.2025 - Xeris Biopharma Fourth Quarter and Full-year 2024 Financial Results Conference Call and Webcast
• 03.06.2025 - Xeris Biopharma Fourth Quarter and Full-year 2024 Financial Results Conference Call and Webcast
• 03.06.2025 - Xeris Biopharma Delivers Record Fourth Quarter and Full-Year 2024 Results; and Announces 2025 Guidance

Recent Filings

• 03.06.2025 - 8-K Current report
• 03.06.2025 - S-3 Registration statement under Securities Act of 1933
• 03.06.2025 - S-8 Securities to be offered to employees in employee benefit plans
• 03.06.2025 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
• 03.06.2025 - EX-99.1 EX-99.1